Top 10 Biopharma IPOs of January—June 2018
Number of Companies Going Public, and the Amount They Raise, Show Growth
Pushing the Right Buttons
Improving Efficacy of Therapeutic DNA Vectors
Blood Protein Linked to Mental Disorders
Consciousness-Aiding Protein Produced by Cells Deep in the Brainstem
Single-Cell Cloning Remains a Challenge
Evolving Technologies Help Make It Easier to Meet Regulatory Requirements
For full access to this article login to GEN Select now.
Navigating the Bench to Bedside Journey
Refining and Adapting Established Approaches to Drug Development
- The field of translational medicine is witnessing rapid maturation as companies focus their efforts on streamlining the passage of drug leads from the bench, through clinical trials, and ultimately to the bedside. In contrast to traditional approaches to early drug development, translational medicine brings human experiments into the discovery ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.